(This is the recording of a live ThinkTank event from 11/19/2025)
PRESENTER: Dr. Catherine “Cat” Savoia, PT, DPT, CIDN, AIB-VRC
Founder, Thrive Physical Therapy | Specialist in Complex Chronic Conditions, Dysautonomia, and Connective Tissue Disorders
Dr. Catherine Savoia is a Doctor of Physical Therapy and founder of Thrive PT, where she provides personalized, whole-person rehabilitation for patients across the lifespan and with a wide range of conditions—from high-level performers and athletes to individuals with complex, chronic conditions. She specializes in dysautonomia (including Postural Orthostatic Tachycardia Syndrome), hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders, as well as Mast Cell Activation Syndrome (MCAS). Drawing on her background in dance education, Dr. Savoia’s career bridges the art and science of movement. She combines advanced manual therapy, vestibular rehabilitation, neural mobilization, and trauma-informed care to address the multifactorial nature of these disorders. Her own experience navigating hEDS, POTS, and MCAS informs her commitment to improving recognition, interdisciplinary collaboration, and patient safety in this underdiagnosed and frequently dismissed population. Dr. Savoia holds certifications in Integrative Dry Needling, Vestibular Rehabilitation, Concussion Management, and Nutrition for Chronic Pain, and continues to advance provider education in the integrative management of dysautonomia and connective tissue disorders.
Email: [email protected]
Website: www.ThrivePTAZ.com
Phone: (781) 799-1337
TOPIC: “The Invisible Trifecta: Recognizing and Reducing Harm in Patients with POTS, EDS, and MCAS”
Patients with Postural Orthostatic Tachycardia Syndrome (POTS), Ehlers-Danlos Syndromes (EDS/HSD), and Mast Cell Activation Syndrome (MCAS) represent a growing but frequently misunderstood segment of the healthcare population. Despite growing prevalence and evolving research, these conditions remain underrecognized, often resulting in misdiagnosis, symptom invalidation, or iatrogenic harm (Raj et al., 2021; Tinkle et al., 2017).
This presentation synthesizes current research, clinical indicators, and best-practice guidelines to support early identification and interdisciplinary management of patients presenting with overlapping autonomic, connective tissue, and immune dysregulation. The session will emphasize trauma-informed care, communication strategies that minimize patient retraumatization, and practical referral frameworks to appropriate specialists.
Dr. Savoia will also highlight the importance of coordinated care between rehabilitation professionals, primary care, allergists/immunologists, and neurologists in optimizing function and quality of life for these patients.
Информация по комментариям в разработке